Springfield Urology Announces Dr. Eric Espinosa's Designation as UroLift® Center of Excellence

Wednesday, May 9, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Designation Recognizes Dr. Eric Espinosa's Commitment to Exemplary Care, Deep UroLift Experience

SPRINGFIELD, Ohio, May 8, 2018 /PRNewswire-PRWeb/ -- Springfield Urology today announced that Dr. Eric

Espinosa has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Espinosa has achieved a high level of training and experience with the UroLift System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia or BPH.

"The UroLift System is a breakthrough minimally invasive treatment that typically takes less than an hour and can offer multiple benefits for men with enlarged prostate – no cutting, heating, or removal of tissue, minimal downtime, no compromise of sexual function, and typically no need for continued medications. I am proud to be a national leader in treating patients with this durable and effective treatment." said Dr. Espinosa

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System NeoTract's FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

Springfield Urology goals is to provide state of the art medical treatment for patients with genitourinary problems. We attempt to provide this in the most compassionate and cost effective way possible. Springfield Urology and Dr. Eric Espinosa are very excited to be given the award of a center of excellence in Urolift. This procedure is changing the treatment process for all men with an enlarged prostate. Giving patients an easy non-invasive way to be symptom free with almost none of the nasty side effects of previous treatments.

Dr. Espinosa joined the practice in 2007. He completed his undergraduate and medical school at the University of Texas and residency at the University of Cincinnati Hospital. He is a board certified urologist and a member of the American Urology Association and the Clark County Medical Society.

# # #

Media Contact: Amy Cramer Amy(at)healthandcommerce(dot)com M: 650-391-3714

 

SOURCE UroLift

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store